Biomaterials-based 3D cell printing for next-generation therapeutics and diagnostics

J Jang, JY Park, G Gao, DW Cho - Biomaterials, 2018 - Elsevier
Building human tissues via 3D cell printing technology has received particular attention due
to its process flexibility and versatility. This technology enables the recapitulation of unique …

[HTML][HTML] Patient-specific organoid and organ-on-a-chip: 3D cell-culture meets 3D printing and numerical simulation

F Zheng, Y **ao, H Liu, Y Fan, M Dao - Advanced biology, 2021 - ncbi.nlm.nih.gov
The last few decades have witnessed diversified in vitro models to recapitulate the
architecture and function of living organs or tissues and contribute immensely to advances in …

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

A Sharma, PW Burridge, WL McKeithan… - Science translational …, 2017 - science.org
Tyrosine kinase inhibitors (TKIs), despite their efficacy as anticancer therapeutics, are
associated with cardiovascular side effects ranging from induced arrhythmias to heart …

Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity

T Magdy, M Jouni, HH Kuo, CJ Weddle, D Lyra-Leite… - Circulation, 2022 - Am Heart Assoc
Background: Multiple pharmacogenomic studies have identified the synonymous genomic
variant rs7853758 (G> A, L461L) and the intronic variant rs885004 in SLC28A3 (solute …

Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer

T Kitani, SG Ong, CK Lam, JW Rhee, JZ Zhang… - Circulation, 2019 - Am Heart Assoc
Background: Molecular targeted chemotherapies have been shown to significantly improve
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …

Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity

A Sharma, WL McKeithan, R Serrano, T Kitani… - Nature protocols, 2018 - nature.com
Cardiotoxicity has historically been a major cause of drug removal from the pharmaceutical
market. Several chemotherapeutic compounds have been noted for their propensities to …

Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy

A Asimaki, S Kapoor, E Plovie, A Karin Arndt… - Science translational …, 2014 - science.org
Arrhythmogenic cardiomyopathy (ACM) is characterized by frequent cardiac arrhythmias. To
elucidate the underlying mechanisms and discover potential chemical modifiers, we created …

iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy

K Kodo, SG Ong, F Jahanbani, V Termglinchan… - Nature cell …, 2016 - nature.com
Left ventricular non-compaction (LVNC) is the third most prevalent cardiomyopathy in
children and its pathogenesis has been associated with the developmental defect of the …

Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening

AST Smith, J Macadangdang, W Leung… - Biotechnology …, 2017 - Elsevier
Improved methodologies for modeling cardiac disease phenotypes and accurately
screening the efficacy and toxicity of potential therapeutic compounds are actively being …

Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: insights into the SENECA trial

CG O'Brien, MO Ozen, G Ikeda, E Vaskova, JH Jung… - Cardio Oncology, 2021 - jacc.org
Background Anthracycline-induced cardiomyopathy (AIC) is a significant source of morbidity
and mortality in cancer survivors. The role of mesenchymal stem cells (MSCs) in treating AIC …